# Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema

> **NCT01492400** · PHASE2 · COMPLETED · sponsor: **Allergan** · enrollment: 363 (actual)

## Conditions studied

- Macular Edema

## Interventions

- **DRUG:** dexamethasone Intravitreal Implant
- **DRUG:** ranibizumab

## Key facts

- **NCT ID:** NCT01492400
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03-09
- **Primary completion:** 2014-02-13
- **Final completion:** 2014-02-13
- **Target enrollment:** 363 (ACTUAL)
- **Last updated:** 2019-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01492400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01492400, "Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT01492400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*